看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Yield10 Bioscience, Inc. |
| Dyadic International, Inc. |
| Onconetix, Inc. |
| Cardiff Oncology, Inc. |
| Geron Corporation |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| YTEN.Q | DYAI | ONCO | CRDF | GERN | CAPS | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 450% | -139% | -234% | -60% | -66% | NM | ||
| Fiscal Year - 1 | -133% | -80% | NA | -47% | -112% | -108% | ||
| Fiscal Year - 2 | -86% | -66% | NA | -31% | -137% | 0% | ||
| Fiscal Year - 3 | -375% | -56% | NA | -21% | -69% | 9% | ||
| Fiscal Year - 4 | -1606% | -29% | NA | -33% | -44% | NA | ||
| Fiscal Year - 5 | -100% | -21% | NA | -192% | -44% | NA | ||
| Average | -308% | -65% | -234% | -64% | -79% | -33% | ||
| Median | -116% | -61% | -234% | -40% | -67% | 0% | ||
| Benchmarks | Ticker | |||||||
| Yield10 Bioscience, Inc. | PINC:YTEN.Q | |||||||
| Dyadic International, Inc. | NasdaqCM:DYAI | |||||||
| Onconetix, Inc. | NasdaqCM:ONCO | |||||||
| Cardiff Oncology, Inc. | NasdaqCM:CRDF | |||||||
| Geron Corporation | NasdaqGS:GERN | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | YTEN.Q | DYAI | ONCO | CRDF | GERN | CAPS | ||
| Latest Fiscal Year | Dec-23 | Dec-24 | Dec-23 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Jun-24 | Dec-24 | Sep-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 1 | 3 | 2 | 1 | 77 | 45 | ||
| Fiscal Year | 0 | 3 | 0 | 1 | 77 | 45 | ||
| Fiscal Year - 1 | 0 | 3 | NA | 0 | 0 | 48 | ||
| Fiscal Year - 2 | 1 | 3 | NA | 0 | 1 | 62 | ||
| Fiscal Year - 3 | 1 | 2 | NA | 0 | 1 | 67 | ||
| Fiscal Year - 4 | 1 | 2 | NA | 0 | 0 | NA | ||
| Fiscal Year - 5 | 1 | 2 | NA | 0 | 0 | NA | ||
| Net Income | ||||||||
| Latest Twelve Months | (13) | (6) | (52) | (45) | (175) | (5) | ||
| Fiscal Year | (14) | (6) | (37) | (45) | (175) | (5) | ||
| Fiscal Year - 1 | (14) | (7) | (14) | (41) | (184) | (6) | ||
| Fiscal Year - 2 | (11) | (10) | (4) | (39) | (142) | (0) | ||
| Fiscal Year - 3 | (10) | (13) | (2) | (28) | (116) | 1 | ||
| Fiscal Year - 4 | (13) | (9) | (1) | (23) | (76) | NA | ||
| Fiscal Year - 5 | (9) | (8) | NA | (17) | (69) | (0) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 6 | 8 | 28 | 82 | 394 | 53 | ||
| Latest Fiscal Quarter | 3 | 10 | 62 | 97 | 594 | 47 | ||
| Fiscal Year | 4 | 10 | 88 | 97 | 594 | 47 | ||
| Fiscal Year - 1 | 8 | 8 | 26 | 82 | 394 | 53 | ||
| Fiscal Year - 2 | 20 | 14 | 3 | 116 | 191 | 65 | ||
| Fiscal Year - 3 | 15 | 21 | 5 | 150 | 226 | 61 | ||
| Fiscal Year - 4 | 17 | 30 | 6 | 135 | 271 | NA | ||
| Fiscal Year - 5 | 13 | 37 | NA | 13 | 166 | 0 | ||
| Fiscal Year - 6 | 17 | 43 | NA | 14 | 185 | 1 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 1 | 6 | 10 | 70 | 248 | 2 | ||
| Latest Fiscal Quarter | (6) | 2 | 34 | 83 | 280 | (3) | ||
| Fiscal Year | (2) | 2 | (6) | 83 | 280 | (3) | ||
| Fiscal Year - 1 | 4 | 6 | 22 | 70 | 248 | 2 | ||
| Fiscal Year - 2 | 16 | 11 | 1 | 106 | 80 | 8 | ||
| Fiscal Year - 3 | 10 | 18 | 5 | 140 | 126 | 6 | ||
| Fiscal Year - 4 | (4) | 28 | 6 | 128 | 211 | NA | ||
| Fiscal Year - 5 | 6 | 36 | NA | 7 | 135 | (3) | ||
| Fiscal Year - 6 | 13 | 42 | NA | 10 | 178 | (1) | ||